Suppression of active, but not total MMP-3, is associated with treatment response in a phase III clinical study of rheumatoid arthritis.
Journal article published in 2017 by
Siebuhr As,
A. S. Siebuhr,
Kjelgaard Petersen Cf,
C. F. Kjelgaard-Petersen,
S. Sun 
,
I. Byrjalsen,
C. Christiansen,
Karsdal,
Karsdal Ma,
Bay Jensen Ac,
A.-C. Bay-Jensen
,
I. Byrjalsen,
C. Christiansen,
Karsdal,
Karsdal Ma,
Bay Jensen Ac,
A.-C. Bay-Jensen
